Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number

Lancet

Volumn 364, Issue 9432, 2004, Pages 438-447

  Price, Ric N ^b,d   Uhlemann, Anne Catrin ^a   Brockman, Alan ^c   McGready, Rose ^b,c   Ashley, Elizabeth ^b,c   Phaipun, Lucy ^c   Patel, Rina ^a   Laing, Kenneth ^a   Looareesuwan, Sornchai ^e   White, Nicholas J ^b,e   Nosten, François ^b,c   Krishna, Sanjeev ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^d MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^e MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; MEFLOQUINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MONOTHERAPY; PATIENT; PLASMODIUM FALCIPARUM; PLASMODIUM FALCIPARUM CALCIUM ATPASE GENE; PLASMODIUM FALCIPARUM CHLOROQUINE RESISTANCE TRANSPORTER GENE; PLASMODIUM FALCIPARUM MULTIDRUG RESISTANT GENE 1; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SAMPLE; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT FAILURE;

EID: 2142769136     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16767-6     Document Type: Article

References (30)

1. White NJ. Antimalarial drug resistance and combination chemotherapy. Philos Trans R Soc Lond B Biol Sci B. 354:1999;739-749
2. Korenromp EL, Williams BG, Gouws E, Dye C, Snow RW. Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. Lancet Infect Dis. 3:2003;349-358
3. Plowe CV. Folate antagonists and mechanisms of resistance. Rosenthal PJ. Antimalarial chemotherapy. 2001;173-190 Humana Press, Totowa
4. Vaidya AB. Atovaquone-proguanil combination. Rosenthal PJ. Antimalarial chemotherapy. 2001;396 Humana Press, Totowa
5. Djimde A, Doumbo OK, Cortese JF, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 344:2001;257-263
6. Nosten F, van Vugt M, Price R, et al. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet. 356:2000;297-302
7. Wilson CM, Volkman SK, Thaithong S, et al. Amplification of pfmdr1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol Biochem Parasitol. 57:1993;151-160
8. Price R, Cassar CA, Brockman A, et al. Pfmdr1 gene amplification and multidrug resistant Plasmodium falciparum on the North West border of Thailand. Antimicrob Agents Chemother. 43:1999;2943-2949
9. Pickard AL, Wongsrichanalai C, Purfield A, et al. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob Agents Chemother. 47:2003;2418-2423
10. Basco LK, Le Bras J, Rhoades Z, Wilson CM. Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa. Mol Biochem Parasitol. 74:1995;157-166
11. Basco LK, de Pecoulas PE, Le Bras J, Wilson CM. Plasmodium falciparum: molecular characterization of multidrug-resistant Cambodian isolates. Exp Parasitol. 82:1996;97-103
12. Zalis MG, Pang L, Silveira MS, Milhous WK, Wirth DF. Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: evidence for quinine resistance. Am J Trop Med Hyg. 58:1998;630-637
13. Luxemburger C, Thwai KL, White NJ, et al. The epidemiology of malaria in a Karen population on the western border of Thailand. Trans R Soc Trop Med Hyg. 90:1996;105-111
14. Brockman A, Paul RE, Anderson TJ, et al. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. Am J Trop Med Hyg. 60:1999;14-21
15. Brockman A, Price RN, van Vugt M, et al. Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. Trans R Soc Trop Med Hyg. 94:2000;537-544
16. Simpson JA, Price R, ter Kuile F, et al. Population pharmacokinetics of mefloquine in patients with acute falciparum malaria. Clin Pharmacol Ther. 66:1999;472-484
17. Duraisingh MT, Jones P, Sambou I, von Seidlein L, Pinder M, Warhurst DC. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol. 108:2000;13-23
18. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1:1986;307-310
19. ter Kuile FO, Luxemburger C, Nosten F, et al. Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg. 89:1995;660-664
20. Price RN, Nosten F, Luxemburger C, et al. Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Trans R Soc Trop Med Hyg. 91:1997;574-577
21. Foote SJ, Thompson JK, Cowman AF, Kemp DJ. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P falciparum. Cell. 57:1989;921-930
22. Price R, Robinson G, Brockman A, Cowman A, Krishna S. Assessment of pfmdr1 gene copy number by tandem competitive polymerase chain reaction. Mol Biochem Parasitol. 85:1997;161-169
23. Barnes DA, Foote SJ, Galatis D, Kemp DJ, Cowman AF. Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum. Embo J. 11:1992;3067-3075
24. Eckstein-Ludwig U, Webb RJ, Van Goethem ID, et al. Artemisinins target the SERCA of Plasmodium falciparum. Nature. 424:2003;957-961
25. Fidock DA, Nomura T, Talley AK, et al. Mutations in the P falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell. 6:2000;861-871
26. Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF. PgH1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature. 403:2000;906-909
27. Foote SJ, Cowman AF. The mode of action and the mechanism of resistance to antimalarial drugs. Acta Tropica. 56:1994;157-171
28. Krishna S, Planche T, Agbenyega T, et al. Bioavailability and preliminary clinical efficacy of intrarectal artesunate in Ghanaian children with moderate malaria. Antimicrob Agents Chemother. 45:2001;509-516
29. Adagu IS, Warhurst DC. Plasmodium falciparum: linkage disequilibrium between loci in chromosomes 7 and 5 and chloroquine selective pressure in Northern Nigeria. Parasitology. 123:2001;219-224
30. Thomas SM, Ndir O, Dieng T, et al. In vitro chloroquine susceptibility and PCR analysis of pfcrt and pfmdr1 polymorphisms in Plasmodium falciparum isolates from Senegal. Am J Trop Med Hyg. 66:2002;474-480